@article{665ddfdb773543e7bd8adeff46c02820,
title = "Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism",
abstract = "Unilateral primary aldosteronism is the most common surgically correctable form of endocrine hypertension and is usually differentiated from bilateral forms by adrenal venous sampling (AVS) or computed tomography (CT). Our objective was to compare clinical and biochemical postsurgical outcomes of patients with unilateral primary aldosteronism diagnosed by CT or AVS and identify predictors of surgical outcomes. Patient data were obtained from 18 internationally distributed centers and retrospectively analyzed for clinical and biochemical outcomes of adrenalectomy of patients with surgical management based on CT (n=235 patients, diagnosed from 1994-2016) or AVS (526 patients, diagnosed from 1994-2015) using the standardized PASO (Primary Aldosteronism Surgical Outcome) criteria. Biochemical outcomes were highly different according to surgical management approach with a smaller proportion in the CT group achieving complete biochemical success (188 of 235 [80%] patients versus 491 of 526 [93%], P<0.001) and a greater proportion with absent biochemical success (29 of 235 [12%] versus 10 of 526 [2%], P<0.001). A diagnosis by CT was associated with a decreased likelihood of complete biochemical success compared with AVS (odds ratio, 0.28; 0.16-0.50; P<0.001). Clinical outcomes were not significantly different, but the absence of a postsurgical elevated aldosterone-to-renin ratio was a strong marker of complete clinical success (odds ratio, 14.81; 1.76-124.53; P=0.013) in the CT but not in the AVS group. In conclusion, patients diagnosed by CT have a decreased likelihood of achieving complete biochemical success compared with a diagnosis by AVS.",
keywords = "Adrenalectomy, Aldosterone, Hyperaldosteronism, Prevalence, Quality of life, Renin",
author = "Williams, {Tracy A.} and Jacopo Burrello and Sechi, {Leonardo A.} and Fardella, {Carlos E.} and Joanna Matrozova and Christian Adolf and Ren{\'e} Baudrand and Stella Bernardi and Felix Beuschlein and Cristiana Catena and Michalis Doumas and Francesco Fallo and Gilberta Giacchetti and Heinrich, {Daniel A.} and Ga{\"e}lle Saint-Hilary and Jansen, {Pieter M.} and Andrzej Januszewicz and Tomaz Kocjan and Tetsuo Nishikawa and Marcus Quinkler and Fumitoshi Satoh and Hironobu Umakoshi and Jǐ{\'i} Widimsk{\'y} and Stefanie Hahner and Stella Douma and Michael Stowasser and Paolo Mulatero and Martin Reincke",
note = "Funding Information: This study was supported by the European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreement No. [694913] to M. Reincke) and by the Deutsche Forschungsgemeinschaft (within the CRC/Transregio 205/1 {"}The Adrenal: Central Relay in Health and Disease{"} to F. Beuschlein, S. Hahner, M. Reincke, and T.A. Williams; grant RE 752/20-1 to M. Reincke and grants BE 2177/13-1 and BE 2177/18-1 to F. Beuschlein) and the Else Kr{\"o}ner-Fresenius Stiftung in support of the German Conns Registry-Else-Kr{\"o}ner Hyperaldosteronism Registry (2013-A182 and 2015-A171 to M. Reincke). L.A. Sechi and C. Catena were supported by a PierSilverio Nassimbeni Foundation research grant and C.E. Fardella by Chilean grants (CONICYT-FONDECYT 1160695 and IMII P09/016-F [ICM]). This study was also supported by the Japanese Ministry of Health, Labour and Welfare (grant for intractable diseases) to F. Satoh and T. Nishikawa; the Ministry of Health of Slovenia (Tertiary Care Scientific grant number 20170018 of the University Medical Centre Ljubljana) to T. Kocjan; G. Saint-Hilary is supported by the Institut de Recherches Internationales Servier (France) and J. Widimsk{\'y} Jr by the Charles University research project PROGRES. Funding Information: This study was supported by the European Research Council under the European Union{\textquoteright}s Horizon 2020 research and innovation program (grant agreement No. [694913] to M. Reincke) and by the Deutsche Forschungsgemeinschaft (within the CRC/Transregio 205/1 “The Adrenal: Central Relay in Health and Disease” to F. Beuschlein, S. Hahner, M. Reincke, and T.A. Williams; grant RE 752/20–1 to M. Reincke and grants BE 2177/13-1 and BE 2177/18-1 to F. Beuschlein) and the Else Kr{\"o}ner-Fresenius Stiftung in support of the German Conns Registry-Else-Kr{\"o}ner Hyperaldosteronism Registry (2013_ A182 and 2015_A171 to M. Reincke). L.A. Sechi and C. Catena were supported by a PierSilverio Nassimbeni Foundation research grant and C.E. Fardella by Chilean grants (CONICYT-FONDECYT 1160695 and IMII P09/016-F [ICM]). This study was also supported by the Japanese Ministry of Health, Labour and Welfare (grant for intractable diseases) to F. Satoh and T. Nishikawa; the Ministry of Health of Slovenia (Tertiary Care Scientific grant number 20170018 of the University Medical Centre Ljubljana) to T. Kocjan; G. Saint-Hilary is supported by the Institut de Recherches Internationales Servier (France) and J. Widimsk{\'y} Jr by the Charles University research project PROGRES. Publisher Copyright: {\textcopyright} 2018 American Heart Association, Inc.",
year = "2018",
doi = "10.1161/HYPERTENSIONAHA.118.11382",
language = "English",
volume = "72",
pages = "641--649",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",
}